海外の治験の状況「1」での検索結果
10032件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Recruiting
- A Pivotal Study to Evaluate Guardian Connect CGM System Performance in China
- Type 1 diabetes, Type 2 diabetes
- China
- 2019-03-25
Recruiting
- Mini-Dose Glucagon to Treat Fasting-induced Hypoglycemia During Ramadan
- Fasting Hypoglycemia;Diabetes Mellitus, Type 1
- Saudi Arabia
- 2019-05-29
Not recruiting
- Determination of Automated Multiple Insulin Dose Injections Settings Using the MDI/SMBG Advisor for Patients With Type 1 Diabetes -Data Collection, Observational & Proof of Concept Study
- Type 1 Diabetes;Multiple Daily Injections
- Israel
- 2019-07-09
Recruiting
- Improvement of stage 1 hypertension by transcutaneous acupoint electrical stimulation based on mobile health: a randomized controlled pilot trial
- Stage 1 Hypertension
- China
- 2019-08-08
Not Recruiting
- Effect of ropivacaine on pain relief in patients of brain surgery
- ASA 1 to 3 patients posted for elective supratentorial craniotomy under general anaesthesia
- India
- 2020-01-16
Recruiting
- Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Sofosbuvir in Treatment-naïve Patients With Chronic Hepatitis C Genotype 1
- Chronic Hepatitis c Genotype 1
- Russian Federation
- 2020-01-27
Not recruiting
- A Study to Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema
- Hereditary Angioedema Types I and II;Hereditary Angioedema Types I and II;Hereditary Angioedema Types I and II
- Australia, Canada, Czech Republic, Czechia, Germany, Hungary, Israel, Italy, Romania, Spain, United Kingdom, United States
- 2014-12-10
Recruiting
- Plasma GLP1 and Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
- Coronary Angiography;Glucagon-Like Peptide 1
- China
- 2016-04-12
Not recruiting
- Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes
- Diabetes;Diabetes Mellitus, Type 1;Diabetes;Diabetes Mellitus, Type 1;Diabetes;Diabetes Mellitus, Type 1
- Bulgaria, Czech Republic, Czechia, Estonia, Finland, Germany, India, Israel, Italy, Japan, Latvia, Lithuania, Poland, Puerto Rico, Russian Federation, Serbia, Turkey, Ukraine, United States
- 2016-01-27
Not Recruiting
- study about symptoms and diagnostic methods of the disease known as vanni pitham in siddha term
- Group 1 1 Age 15-70 yrs 2 Bloody diarrhoea 3 diarrhoea with mucus Group 2 1 Abdominal discomfort 2 Fever 3 Lethargy 4 Anorexia 5 Anaemia 6 Sour taste
- India
- 2017-06-02
Recruiting
- Clinical Trial of YH25448 in Patients With EGFR Mutation Positive Advanced NSCLC
- EGFR Gene Mutation
- Korea, Republic of
- 2017-01-26
Not recruiting
- Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart Compared to NovoRapid® in Adults With Type 1 Diabetes
- Diabetes;Diabetes Mellitus, Type 1;Diabetes;Diabetes Mellitus, Type 1;Diabetes;Diabetes Mellitus, Type 1
- Belgium, Canada, France, Germany, Netherlands, Russian Federation, Slovenia, United Kingdom, United States
- 2016-07-04
Recruiting
- EGFR-TKIs Combine With Anlotinib as First-line Treatment for Patients With Advanced EGFR Mutation-positive NSCLC
- EGFR Gene Mutation
- China
- 2018-10-24
Not recruiting
- National Evaluation of PI-based 2nd Line Efficacy in Cambodia
- HIV
- Cambodia
- 2013-02-22
Not Recruiting
- A Phase II Trial of QYHJ Granules Versus Xeloda in Second Line Therapy of Metastatic Pancreatic Cancer
- pancreatic cancer
- China
- 2013-02-20
Recruiting
- The effect of GLP-1 analogue on cognitive decline in diabetes: A resting-state fMRI study on type 2 diabetes
- diabetes
- China
- 2013-02-17
Not recruiting
- Long-term Follow up Helicobacter Pylori Reinfection Rate After Second-Line Treatment: Bismuth-Containing Quadruple Therapy Versus Moxifloxacin-Based Triple Therapy
- Helicobacter Infections
- Korea, Republic of
- 2013-02-12
Not recruiting
- ARCHER-1050: A Study of Dacomitinib vs. Gefitinib in 1st-Line Treatment Of Advanced NSCLC.
- EGFR Positive Non-small Cell Lung Cancer
- China, Hong Kong, Italy, Japan, Korea, Republic of, Poland, Spain
- 2013-01-21
Authorised
- MK-3475 vs. Docetaxel in Second-Line Non-Small Cell Lung Cancer
- MedDRA version: 20.0 Level: LLT Classification code 10066490 Term: Progression of non-small cell lung cancer System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, Australia, Belgium, Brazil, Canada, Chile, Czech Republic, Denmark, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Lithuania, Netherlands, Portugal, Russian Federation, South Africa, Spain, Taiwan, United Kingdom, United States
- 2013-01-17
Recruiting
- Comparison of Sequencing and PNA Clamping of EGFR Gene in Patients With Non-Small Cell Type Lung Cancer
- Non-Small Cell Lung Cancer
- Korea, Republic of
- 2013-01-11
